Drug intelligence / Profile preview

honey mixture

Development stage: Unknown
Modality: Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
Administration: Topical

Overview

Honey mixture is a topical preparation composed of honey, beeswax, and olive oil in a 1:1:1 ratio. It has been investigated for its effects on patients with atopic dermatitis and psoriasis vulgaris. Clinical studies have shown that the honey mixture can lead to significant improvement in symptoms for both conditions and may allow for a reduction in the dosage of topical corticosteroids when used in combination. Its therapeutic benefits are likely attributed to the known properties of its natural ingredients, which can include anti-inflammatory, moisturizing, and antimicrobial effects.

Beyond the preview

Go deeper on honey mixture.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on honey mixture.

Explore the full profile